Kevin Charles Gorman, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 616,500 shares at $110.22 ($67.9M) on 2021-01-08, disclosed to the SEC on 2021-01-12.
Seasonal sale ($67.9M) by Chief Executive Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.21 | 143,449 | $15.8M | 23.3% |
| 2 | $110.21 | 143,449 | $15.8M | 23.3% |
| 3 | $110.22 | 164,801 | $18.2M | 26.7% |
| 4 | $110.22 | 164,801 | $18.2M | 26.7% |
| Total | $110.22 avg | 616,500 | $67.9M | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |